Healthcare

Lumos Diagnostics Holdings Ltd (ASX:LDX) is a medical diagnostics company focused on developing rapid point-of-care testing solutions. Its lead product, FebriDx, is designed to help clinicians assess whether an acute respiratory infection is more likely bacterial or viral. This article examines how regulatory progress …

Alterity Therapeutics Ltd (ASX:ATH) is a clinical-stage biotechnology company focused on developing treatments for neurodegenerative diseases. Its lead programme, ATH434, is an investigational oral therapy being developed for multiple system atrophy (MSA), a rare and progressive neurological disorder. This article examines the clinical progress …

PYC Therapeutics Limited (ASX:PYC) is a Perth-based clinical-stage biotechnology company developing RNA-based medicines. The company focuses on improving delivery of oligonucleotide therapies into cells using its proprietary peptide-based delivery technology. This article examines PYC’s delivery platform, VP-001 development programme and the factors shaping its …

Vitrafy Life Sciences Ltd (ASX:VFY) is a medical technology company focused on improving the way biological materials are frozen, stored and transported. The company has developed a cryopreservation system combining controlled-rate freezing equipment with digital monitoring capabilities. This article examines Vitrafy’s technology platform, validation …

Tetratherix Limited (ASX:TTX) is an Australian medical technology company developing injectable biomaterials designed to support tissue repair and regeneration. The company’s Tetramatrix platform forms the foundation of multiple medical device applications. This article examines Tetratherix’s technology platform, product development activities and the factors shaping …

Nyrada Inc. (ASX:NYR) is a clinical-stage biotechnology company developing therapies designed to protect cells following acute injury. The company’s lead candidate, Xolatryp, is being investigated for applications involving heart injury after heart attacks and neurological damage following brain injury. This article reviews Nyrada’s technology …

Memphasys Limited (ASX:MEM) is an Australian reproductive biotechnology company developing fertility solutions for assisted reproduction. The company’s Felix system is designed to support sperm selection during in-vitro fertilisation procedures. This article reviews the technology platform, commercial progress and the factors influencing Memphasys’ development pathway.